Certified by Founder
Lodge
Ganymede
start up
United States
- Palo Alto, California
- 26/12/2022
- Series A
- $12,750,000
Ganymede is the first PaaS for biotech software engineering. Quickly integrate apps, import data, or design pipelines using a powerful bio-aware low-code platform.
- Industry Software Development
- Website https://www.ganymede.bio/
- LinkedIn https://www.linkedin.com/company/ganymede-inc/
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)